can glp 1 cause low blood sugar The Role of GLP-1 Signaling in Hypoglycemia due to Hyperinsulinism GLP-1 and Its Role in

people with malabsorption disorders such as inflammatory bowel diseases and celiac disease

Safety of liraglutide in type 2 diabetes and chronic kidney disease

Provider expertise in metabolic medicine and understanding of individual risk stratification ensures safe treatment decisions

Mitochondria-targeted antioxidants hold great promising and may serve as a useful approach for the alleviation of age-related diseases

Clinical trial data shows that at the 2.5 mg starting dose, gastrointestinal adverse events are significantly lower than at therapeutic doses of 10 or 15 mg

Response to resmetirom therapy should also be addressed in a specific subgroup of patients after stratifying them according to their lack of response to lifestyle intervention with Mediterranean diet and structured aerobic physical activity